Citations

Showing 10 of 108152 citations.

Treatment‐induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider
El‐Khoury, Habib , Saifi, Omran , Haddad, Salame, Chahrour, Mohamad , Ghanem, Khaled , Mubarak, Yaacoub, Tamim, Hani , Makki, Maha , Zakka, Cyril , Chan, Anthony K.C. , Mahfouz, Rami , Tarek, Nidale , El‐Solh, Hassan, Abboud, Miguel R. , Saab, Raya , Muwakkit, Samar , Saifi, Omran , Muwakkit, Samar A , Chan, Anthony K C , Saifi, Omran

Mayo Clinic

Pediatric Blood & Cancer | July 30, 2021 | Volume: 68 | Issue: 11 | Pages: No page available

10.1002/pbc.29210 | PMID 34327817 Get It

AbstractBackgroundCerebral sinus venous thrombosis (CSVT) is one of the many side effects encountered during acute lymphoblastic leukemia (ALL) therapy. Due to the rarity of cases, lack of data, and consensus management, no recommendations exist to target the population at risk.MethodsThis is a retrospective chart review of 229 consecutive patients diagnosed with ALL with an age range of 1–21 years, treated at the Children's Cancer Center of Lebanon between October 2007 and February 2018.ResultsThe incidence of CSVT was 10.5%. Using univariate analysis, increased risk of CSVT was observed with male gender, age >10 years, T‐cell immunophenotype, intermediate/high‐risk disease, maximum triglyceride (TG) level of >615 mg/dl, presence of mediastinal mass, and larger body surface area (BSA). With multivariate analysis, the only statistically significant risk factors were maximum TG level, BSA, presence of mediastinal mass, and risk stratification (intermediate/high risk).ConclusionOur study was able to unveil TG level of >615 mg/dl, mediastinal mass, and a larger BSA as novel risk factors that have not been previously discussed in the literature.
Investigating the Chronology of Meniscus Root Tears: Do Medial Meniscus Posterior Root Tears Cause Extrusion or the Other Way Around?
LaPrade, Matthew D. , Wilbur, Ryan R. , Song, Bryant M. , Rhodes, Nicholas P. , Johnson, Adam, Hevesi, Mario , Rhodes, Nicholas, Johnson, Adam, Camp, Christopher L. , Stuart, Michael J. , Krych, Aaron J.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | July 30, 2021 | Volume: 9 | Issue: 7_suppl4 | Pages: No page available

10.1177/2325967121s00203 Get It

Objectives: Meniscus root tears are increasingly being recognized. Meniscus extrusion has previously been associated with medial root tears; however, the relationship between secondary meniscus restraints, such as the meniscotibial (MT) ligament, extrusion, and root tears has yet to be formally evaluated. The purpose of this study was to better understand the association between MT ligament competence, medial meniscus extrusion, and medial meniscus posterior root tears (MMPRT), as well as to determine the progression of meniscus extrusion over time. Methods: Serial MRI’s from our institution were reviewed for patients who showed evidence of medial meniscus extrusion and MMPRT on at least one of 2+ available MRI’s. All patients were symptomatic at the time of diagnosis. All MRI’s were analyzed independently by two board-certified musculoskeletal radiologists. MT ligament disruption, medial meniscus extrusion, and MMPRT presence was recorded for each MRI. The time between MRI’s, presence of insufficiency fractures, and Outerbridge classification for the medial femur and tibia were also evaluated. Results: 27 knees in 26 patients were included in this study, with a total of 63 MRI’s analyzed (21 knees with 2 MRI’s, 3 with 3 MRI’s, and 3 with 4 MRI’s). All patients demonstrated clear medial meniscus extrusion and meniscotibial ligament disruption prior to the subsequent development of MMPRTs (p < 0.001). Mean extrusion at the time of initial MRI was 3.3 ± 1.1 mm, and increased significantly to 5.5 ± 1.8 mm at the time of first imaging with an identified MMPRT (p < 0.001). The average time between initial MRI and the first identification of MMPRT on a later MRI was 1.7 ± 1.6 years. Conclusions: In a sample of 27 symptomatic knees with serial MRI’s both before and after MMPRT diagnosis, all patients demonstrated MT ligament disruption and associated meniscus extrusion prior to the development of subsequent medial meniscus root tears. These findings suggest that MT ligament disruption and medial meniscus extrusion represent early and predisposing events contributing to MMPRT. Therefore, this provides a possible explanation of why meniscus extrusion is not corrected with medial meniscus root repair.
Muscle-Derived Cytokines Reduce Growth, Viability and Migratory Activity of Pancreatic Cancer Cells
Schwappacher, Raphaela , Dieterich, Walburga , Reljic, Dejan , Pilarsky, Christian , Mukhopadhyay, Debabrata , Chang, David K. , Siebler, Jürgen, Herrmann, H , Neurath, Markus F. , Zopf, Yurdagül , Herrmann, Hans J , Zopf, Yurdagül , Mukhopadhyay, Debabrata , Chang, David , Biankin, Andrew V.

Mayo Clinic

Cancers | July 29, 2021 | Volume: 13 | Issue: 15 | Pages: 3820

10.3390/cancers13153820 | PMID 34359731 Get It

The evidence that regular physical exercise reduces the risk of developing cancer is well described. However, the interaction between physical exercise and cancer is not fully clarified yet. Several myokines released by skeletal muscle appear to have a direct anti-tumour function. There are few data on myokine secretion after exercise in patients with advanced tumours. Pancreatic cancer (PC) is a very aggressive and usually fatal cancer. To investigate the effects of exercise in PC, the blood of advanced-stage PC patients was analysed after 12 weeks of resistance training using whole-body electromyostimulation. After the 12-week training period, the patient serum inhibited the proliferation and the motility of PC cells and enhanced PC cell apoptosis. The impact of exercise training was also investigated in an exercise-mimicking in vitro model using electric pulse stimulation of human myotubes and revealed similar anti-tumour effects on PC cells, clearly indicating direct cancer-protective properties of activated skeletal muscle. Protein and gene expression analyses in plasma from exercise-trained patients and in myotube cultures after in vitro exercise showed that interleukin 10 (IL10), C-X-C motif ligand 1 (CXCL1) and C-C motif chemokine ligand 4 (CCL4) are myokines released from activated skeletal muscle. In accordance with the effects of serum from exercise-trained patients, the supplementation with recombinant IL10, CXCL1 and CCL4 impaired growth and migration of PC cells. Treatment of PC cells with these myokines upregulated caspase 3/7 expression and the cleavage of poly(ADP-ribose) polymerase, leading to enhanced PC cell death. The identification of myokines with anti-tumour properties in advanced-stage PC patients after exercise opens a new perspective in supportive therapy with sports and exercise for cancer patients.
COVID-19 and Vaccination in the Setting of Neurologic Disease
Kornberg, Michael D. , Kessler, Kevin, Haq, Ihtsham , Patel, Anup D. , Nath, Avindra , Schierman, Becky, Marsh, Elisabeth B , Kornberg, Michael , Haq, Ihtsham , Patel, Anup D , Nath, Avindra , Jones, Lyell K , Kessler, Kevin, Jones, Lyell K.

Mayo Clinic

Neurology | July 29, 2021 | Volume: 97 | Issue: 15 | Pages: 720-728

10.1212/wnl.0000000000012578 | PMID 34326180 Get It

A Pilot Study of Ponatinib in Patients With FGFR-Altered Advanced Cholangiocarcinoma
Ahn, Daniel H. , Usón, Pedro Luiz Serrano , Masci, Peter, Mody, Kabir , DeLeon, Thomas, Gores, Gregory, Smoot, Rory L. , Bekaii‐Saab, Tanios , Mansfield, Aaron, Smoot, Rory L , Uson, Pedro L S , Bekaii-Saab, Tanios S , Kosiorek, Heidi , Hálfdánarson, Þorvarður R. , Babiker, Hani M. , Sonbol, Mohamad Bassam , Mahipal, Amit , Tran, Nguyen H. , Hubbard, Joleen M. , Borad, Mitesh J.

Mayo Clinic

No container title available | July 29, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-741191/v1 Get It

Abstract Background:Biliary tract cancers (BTC) are rare, chemo resistant and are associated with a poor prognosis. Preclinical and early clinical work had demonstrated interesting anti-tumor activity from targeting fibroblast growth factor receptor (FGFR) pathway. We hypothesized that ponatinib, a multi-targeted tyrosine kinase inhibitor with activity against FGFR, would be active in BTC patients with FGFR alterations.Methods:This was a multi-center, single institution pilot study of ponatinib in patients with advanced, refractory BTC with FGFR alterations. The primary end point was overall response rate, with secondary points of overall survival (OS), progression-free survival (PFS) and Health Related Quality of Life (HRQoL) assessment. Results:Twelve patients were enrolled prior to early termination of the trial. Clinical benefit (defined as complete/partial response + stable disease) of 45.5% was observed. All observed toxicities were manageable and reversible. Toxicities were mild, with lymphopenia (75%), rash (63%) and fatigue (50%) being the most frequent. No significant detriment in global QoL was observed.Conclusions:Ponatinib as a single agent in FGFR altered BTC is tolerable with very modest clinical activity. This is the first report of prospective assessment of FGFR inhibition in BTC using ponatinib, and the first study to report its effect on HRQoL. Further development of ponatinib will involve correlative studies to better refine patient selection, focus on combinations with other molecular targeted agents, conventional cytotoxic chemotherapy, and studies to better understand mechanisms of treatment resistance.
Thymic stromal lymphopoietin induces adipose loss through sebum hypersecretion
Choa, Ruth , Tohyama, Junichiro , Wada, Shogo , Meng, Hu , Hu, Jian , Okumura, Mariko, May, Rebecca M., Robertson, Tanner F. , Pai, Ruth-Anne Langan , Nace, Arben , Hopkins, Christian , Jacobsen, Elizabeth A. , Haldar, Malay , Behrens, Edward M. , Minn, Andy J. , Seale, Patrick , Cotsarelis, George , Li, Mingyao , Kambayashi, Taku , FitzGerald, Garret A , Behrens, Edward M , Kim, Brian , Seykora, John T , Li, Mingyao , Arany, Zoltan Pierre , Kambayashi, Taku , Jacobsen, Elizabeth A

Mayo Clinic

Science | July 29, 2021 | Volume: 373 | Issue: 6554 | Pages: No page available

10.1126/science.abd2893 | PMID 34326208 Get It

Sweat out the fat with TSLP! Thymic stromal lymphopoietin (TSLP) is a cytokine that can promote immune responses that characterize allergic diseases. Choa et al . found that mice engineered to produce elevated TSLP displayed selective white adipose tissue loss that protected them from obesity, insulin resistance, and steatohepatitis (see the Perspective by Schneider). Protection was not mediated by eosinophils, regulatory T cells, or innate lymphoid cells. Rather, TLSP induced the migration of conventional T cells to sebaceous glands in the skin. Once there, these T cells promoted white adipose tissue loss by the hypersecretion of sebum, a lipid-rich substance that augments the skin’s barrier function. This mechanism, which likely evolved to enhance cutaneous antimicrobial defenses, could be possibly targeted in future treatments for obesity. —STS
Circadian rhythms of 11-oxygenated C19 steroids and ∆5-steroid sulfates in healthy men
Turcu, Adina F. , Zhao, Lili , Chen, Xuan , Yang, Rebecca , Rege, Juilee , Rainey, William E. , Veldhuis, Johannes D. , Auchus, Richard J. , Zhao, Lili , Turcu, Adina F

Mayo Clinic

European Journal of Endocrinology | July 29, 2021 | Volume: 185 | Issue: 4 | Pages: K1-K6

10.1530/eje-21-0348 | PMID 34324429 Get It

Background Many hormones display distinct circadian rhythms, driven by central regulators, hormonal bioavailability, and half-life. A set of 11-oxygenated C19 steroids (11-oxyandrogens) and pregnenolone sulfate (PregS) are elevated in congenital adrenal hyperplasia and other disorders, but their circadian patterns have not been characterized. Participants and methods Peripheral blood was collected every 2 h over 24 h from healthy volunteer men (10 young, 18–30 years, and 10 older, 60–80 years). We used mass spectrometry to quantify 15 steroids, including androstenedione (A4), testosterone (T), 11β-hydroxy- and 11-ketotestosterone (11OHT, 11KT),11β-hydroxy- and 11-ketoandrostenedione (11OHA4, 11KA4), and 4 ∆5-steroid sulfates. Diurnal models including mesor (rhythm adjusted median), peak, and nadir concentrations, acrophase, and amplitude were computed. Results 11OHA4 followed a rhythm similar to cortisol: acrophase 8:00 h, nadir 21:00 h and were similar in young and old men. 11KT had similar diurnal patterns, but the peak was lower in older than in young men, as was the case for A4. All four steroid sulfates were higher in young vs older men. PregS and 17-hydroxypregnenolone sulfate (17OHPregS) showed sustained elevations between 8:00 and 18:00 h, and nadirs around midnight, while DHEAS and AdiolS displayed minimal diurnal variations. All 4 11-oxyandrogens correlated tightly with cortisol (r from 0.54 for 11OHT to 0.81 for 11OHA4, P < 0.0001 for all), but very weakly with T, supporting their adrenal origin and ACTH governance. Conclusions 11-Oxyandrogens, PregS, and 17OHPregS display distinct circadian and age variations, which should be accounted for when used as clinical biomarkers.
Syringol Isolated From Eleusine Coracana (L.) Gaertn Bran Suppresses Inflammatory Response Through the Down-Regulation of cPLA2, COX-2, IκBα, p38 and MPO Signaling in sPLA2 Induced Mice Paw Edema.
Gowda, Mallanayakanakatte D. Milan, Jayachandra, K., Joshi, Vikram , Manjuprasanna, Vaddarahally N. , Velmurugan, Devadasan, Jameel, Noor Mohamed, Vishwanath, Bannikuppe S. , Rudresha, Gotravalli V. , Pachaiappan, Raman , Joshi, Vikram

Mayo Clinic

No container title available | July 29, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-755579/v1 Get It

Abstract Eleusine coracana (L.) Gaertn (E. coracana) is one of the highest consuming food crops in Asia and Africa. E. coracana is a plant with several medicinal values including anti-ulcerative, anti-diabetic, anti-viral and anti-cancer properties. However, the anti-inflammatory property of E. coracana remains to be elucidated. Therefore, the objective of present study was to investigate the potential in isolated molecule from E. coracana via a combination of in vitro, in vivo and in silico methods. In this study we have isolated, purified and characterized an anti-inflammatory molecule from E coracana bran extract known as syringol. Purification of syringol was accomplished by combination of GC-MS and RP-HPLC techniques. Syringol significantly inhibited the enzyme activity of sPLA2 (IC50 = 3 µg) and 5-LOX (IC50 = 0.325 µg) in vitro. The inhibition is independent of substrate concentration, calcium ion concentration and was irreversible. Syringol interacts with purified sPLA2 enzymes as evidenced by fluorescence and molecular docking studies. Further, the syringol molecule dose dependently inhibited the development of sPLA2 and carrageenan induced edema. Furthermore, syringol decreases the expression of cPLA2, COX-2, IκBα, p38 and MPO in edematous tissues as demonstrated by western blots. These studies revealed that syringol isolated from E coracana bran may develop as a potent anti-inflammatory molecule.
TCF7L2 Genetic Variants Do Not Influence Insulin Sensitivity or Secretion Indices in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes
Redondo, María J. , Warnock, Megan, Libman, Ingrid , Bocchino, Laura E., Cuthbertson, David , Geyer, Susan, Pugliese, Alberto , Steck, Andrea K. , Becker, Dorothy J., Sosenko, Jay M. , Bacha, Fida , Group, the Type 1 Diabetes TrialNet Study, Evans‐Molina, Carmella , Group, the Type 1 Diabetes TrialNet Study

Mayo Clinic

Diabetes Care | July 29, 2021 | Volume: 44 | Issue: 9 | Pages: 2039-2044

10.2337/dc21-0531 | PMID 34326068 Get It

OBJECTIVE We aimed to test whether type 2 diabetes (T2D)–associated TCF7L2 genetic variants affect insulin sensitivity or secretion in autoantibody-positive relatives at risk for type 1 diabetes (T1D). RESEARCH DESIGN AND METHODS We studied autoantibody-positive TrialNet Pathway to Prevention study participants (N = 1,061) (mean age 16.3 years) with TCF7L2 single nucleotide polymorphism (SNP) information and baseline oral glucose tolerance test (OGTT) to calculate indices of insulin sensitivity and secretion. With Bonferroni correction for multiple comparisons, P values &lt; 0.0086 were considered statistically significant. RESULTS None, one, and two T2D-linked TCF7L2 alleles were present in 48.1%, 43.9%, and 8.0% of the participants, respectively. Insulin sensitivity (as reflected by 1/fasting insulin [1/IF]) decreased with increasing BMI z score and was lower in Hispanics. Insulin secretion (as measured by 30-min C-peptide index) positively correlated with age and BMI z score. Oral disposition index was negatively correlated with age, BMI z score, and Hispanic ethnicity. None of the indices were associated with TCF7L2 SNPs. In multivariable analysis models with age, BMI z score, ethnicity, sex, and TCF7L2 alleles as independent variables, C-peptide index increased with age, while BMI z score was associated with higher insulin secretion (C-peptide index), lower insulin sensitivity (1/IF), and lower disposition index; there was no significant effect of TCF7L2 SNPs on any of these indices. When restricting the analyses to participants with a normal OGTT (n = 743; 70%), the results were similar. CONCLUSIONS In nondiabetic autoantibody-positive individuals, TCF7L2 SNPs were not related to insulin sensitivity or secretion indices after accounting for BMI z score, age, sex, and ethnicity.
Outcomes of the keystone perforator island flap for oncologic reconstruction of the back
Yan, María , Rose, Peter S. , Moran, Steven L. , Houdek, Matthew T.

Mayo Clinic

Journal of Surgical Oncology | July 29, 2021 | Volume: 124 | Issue: 7 | Pages: 1002-1007

10.1002/jso.26629 | PMID 34324204 Get It

AbstractBackgroundCoverage of posterior trunk defects after tumor resection can be challenging due to the intricate anatomy. The keystone perforator island flap (KPIF) provides coverage of the defect without the need for distant flap coverage or microsurgery, matches the recipient's skin color and contour, and requires a short operative time.MethodsA retrospective review of all oncological back reconstructions with KPIF was performed at our institution. The patient comorbidities and surgical outcomes were collected.ResultsA total of 17 patients underwent 20 KPIF (15 single and 2 double) for back reconstruction. Surgical indications were sarcoma (n = 12) and melanoma (n = 5). The mean age at surgery was 47.3 years (SD 23.3). The flaps were located in the upper back (n = 8), paraspinal (n = 4), middle back (n = 6), and lower back (n = 2). The average wound size after sarcoma and melanoma excision were 231.6 ± 297.4 and 156.7 ± 269.7 cm2, respectively. Four patients required an additional planned skin graft and one patient underwent a simultaneous myocutaneous latissimus dorsi flap. The mean operative time, including tumor resection, was 256 min (SD 118). The median length‐of‐hospital stay was 3 days (Q1–3: 1–6.5) and the median follow‐up time was 35.3 months (Q1–3: 13.3–53.1). All flaps survived with minor surgical complications which included hematoma (n = 1), surgical site infection requiring debridement (n = 1), superficial wound dehiscence (n = 1), cellulitis (n = 1), and seroma (n = 1). The reconstructions were successful in 100% of patients.ConclusionsThe KPIF is a reliable and safe option for reconstruction of oncological back defects with minimal perioperative complications. This flap option avoids the use of free flaps and myocutaneous flaps for moderate‐sized back defects.